Acasti Pharma is a startup. 1 investor tracked.
Acasti Pharma is a startup founded in 2018 based in the United States. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Grace Therapeutics is a late-stage biopharma company developing GTx-104, an intravenous infusion of nimodipine for treating aneurysmal subarachnoid hemorrhage (aSAH), a rare and life-threatening condition.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.